Virtus Health's share price rises

There's still a lot to like, but with the share price up 15% since our last review, it's time to downgrade.

IVF provider Virtus Health's share price has risen 57% since its low last August and is up 15% since Australia's 9,000 missing babies from 6 Apr 16 (Buy $6.22). The stock now sports a price-earnings ratio of 17 based on 2016 estimates and a dividend yield of 3.9%. Virtus benefits from economies of scale, has plenty of free cash flow and decent growth prospects, but having brushed past our recommended Buy price, we're downgrading to HOLD.

Note: The Intelligent Investor Growth Portfolio and Equity Income Portfolio own shares in Virtus Health. You can find out about investing directly in Intelligent Investor and InvestSMART portfolios by clicking here.

{{content.question}}

{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa
Mastercard

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device


Register as a new member

(using a different email)

Related Articles